Location History:
- Los Angeles, CA (US) (1985 - 1997)
- Pacific Palisades, CA (US) (1998 - 2001)
Company Filing History:
5 out of 36 
3 out of 15,528 
1 out of 45 
Years Active: 1985-2001
Title: Reiko F Irie: Pioneering Innovations in Cancer Treatment
Introduction
Reiko F Irie is a distinguished inventor based in Los Angeles, CA, who has made significant contributions to the field of cancer research. With a total of nine patents to her name, she has focused her work on developing innovative methods for treating cancer through the discovery of tumor-associated proteins.
Latest Patents
Among her latest patents is a groundbreaking method of treating cancer that involves a 43 kD human cancer antigen. This tumor-associated protein has been found to exhibit immunoreactivity to the human monoclonal antibody L92. Irie has isolated a ten amino acid peptide segment of this protein, as well as a fourteen amino acid peptide that contains the ten amino acid segment, both of which show immunoreactivity to the same antibody. Through the use of truncated fusion proteins, she determined that the minimum recognition site for antibody binding is four amino acids. Additionally, her patents disclose polypeptide compositions against human tumors, which include the polypeptides or proteins of her research, as well as antibodies that may be used directly for treatment or diagnosis. A notable embodiment of her invention includes the DNA sequences encoding both the ten amino acid peptide and the fourteen amino acid peptide, which also exhibit immunoreactivity to human monoclonal antibody L92 and cytotoxic T cells.
Career Highlights
Reiko F Irie has worked with prominent institutions such as the John Wayne Cancer Institute and the University of California. Her research has been instrumental in advancing the understanding of cancer treatment methodologies.
Collaborations
Some of her notable coworkers include Takanori Oka and Tadashi Tai, who have collaborated with her on various research projects.
Conclusion
Reiko F Irie's innovative work in cancer treatment exemplifies the impact of dedicated research and invention in the medical field. Her contributions continue to pave the way for advancements in cancer therapies.